学术探索
学术期刊
新闻热点
数据分析
智能评审

DESIGN AND FORMULATION OF SUSTAINED-RELEASE THEOPHYLLINE DOSAGE FORMS

被引：11
作者：
SHANGRAW, RF
机构：
来源：
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY | 1988年 / 14卷 / 2-3期
关键词：
D O I：
10.3109/03639048809151973
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：319 / 335
页数：17
相关论文
共 10 条
[1]  
DAVID S, 1984, Patent No. 4465660
[2]  
GONZALEZ M, 1963, DRUG DEV IND PHARM, V9, P1379
[3]   A CLINICAL AND PHARMACOKINETIC BASIS FOR THE SELECTION AND USE OF SLOW RELEASE THEOPHYLLINE PRODUCTS [J].
HENDELES, L ;
IAFRATE, RP ;
WEINBERGER, M .
CLINICAL PHARMACOKINETICS, 1984, 9 (02) :95-135
[4]  
HERMELIN, 1956, Patent No. 2736682
[5]   ORAL PROLONGED ACTION MEDICAMENTS - THEIR PHARMACEUTICAL CONTROL AND THERAPEUTIC ASPECTS [J].
LAZARUS, J ;
COOPER, J .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1959, 11 (05) :257-290
[6]   SOLUTION RATE OF THEOPHYLLINE SALTS AND EFFECTS FROM ORAL ADMINISTRATION [J].
NELSON, E .
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1957, 46 (10) :607-614
[7]  
RIDOLFO AS, 1959, AM J MED SCI, V81, P585
[8]  
SHEPARD M, 1963, Patent No. 3109775
[9]  
ULLMAN M, 1981, Patent No. 4258027
[10]  
1983, THEO 24 CLIN PROFILE
1